MeSH

Inorganic binary compounds of iodine or the I- ion.

A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function tests.

Year introduced: 1991(1979)

An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)

Year introduced: 1965

A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.

Year introduced: 1986(1976)

A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma.

Year introduced: 1965

A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.

Year introduced: 2001(1972)

located in the basolateral end of the thyroid follicular cells; involved in the biosynthesis of triiodothyronine & thyroxine; amino acid sequence known; RefSeq NM_000453 (human), NM_053248 (mouse), NM_052983 (rat)

Date introduced: September 27, 1991

RN given refers to unlabeled cpd with MF of CH3-I

Date introduced: January 1, 1977

A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)

structure given in first source: RN refers to iodide, (2S(-)-(2alpha,4beta,5alpha)-isomer)

Date introduced: September 19, 1992

analog of muscarine where furan ring is replaced by cyclopentane ring; structure

Date introduced: January 1, 1974

RN given refers to endo-(+-)-isomer; structure in Negwer, 5th ed, #3766

Date introduced: January 1, 1969

A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.

Year introduced: 1992(1964)

degradation product of clidinium bromide; structure in first source

Date introduced: August 22, 1997

RN given for parent cpd

Date introduced: September 12, 1991

see also record for clidinium compounds; RN given refers to cpd without isomeric designation

Date introduced: March 24, 1988

carbamoylating reagent; RN given refers to iodide ; RN for parent cpd not in Chemline 7/26/83

Date introduced: June 16, 1982

RN given refers to bromide

Date introduced: January 1, 1972

A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.

Year introduced: 1998

A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.

Year introduced: 1991(1975)